Search
Sep 21, 2024
The CEO of BioArctic talks Leqembi and what's next in Alzheimer's, Parkinson's, ALS, and more
Gunilla Osswald talks about the global approvals Leqembi has received, she makes the case for a European approval, and talks about what...
Sep 21, 2024
Lars Lannfelt, inventor of the approved (in the U.S. and elsewhere) Alzheimer's medicine Leqembi, describes how the drug works and shares his understanding of Alzheimer's disease
Professor Lannfelt recounts the history of researching amyloid beta and explains why he thinks it is vital to target amyloid beta...